The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bluebird bio Inc shares valued at $9,311 were sold by Obenshain Andrew on Mar 04 ’24. At $1.53 per share, Obenshain Andrew sold 6,095 shares. The insider’s holdings dropped to 279,998 shares worth approximately $0.32 million following the completion of this transaction.
Also, Klima Thomas J sold 4,573 shares, netting a total of over 6,986 in proceeds. Following the sale of shares at $1.53 each, the insider now holds 124,840 shares.
Before that, Colvin Richard A had sold 6,770 shares from its account. In a trade valued at $10,342, the Chief Medical Officer traded Bluebird bio Inc shares for $1.53 each. Upon closing the transaction, the insider’s holdings decreased to 6,770 shares, worth approximately $0.14 million.
As published in a research note from HSBC Securities on December 11, 2023, Bluebird bio Inc [BLUE] has been rated down from a Hold to a Reduce. Analysts at Morgan Stanley upgraded the stock from ‘”an Underweight”‘ to ‘”an Equal-weight”‘ outlook in a report released in early December. As of October 17, 2023, Cantor Fitzgerald has initiated its “Neutral” rating for BLUE. Earlier on September 06, 2023, HSBC Securities initiated its rating. Their recommendation was “a Buy” for BLUE stock.
Analyzing BLUE Stock Performance
During the last five days, there has been a drop of approximately -5.69%. Over the course of the year, Bluebird bio Inc shares have dropped approximately -15.94%. Shares of the company reached a 52-week high of $1.9200 on 02/27/24 and a 52-week low of $0.8790 on 02/06/24. A 50-day SMA is recorded $1.2566, while a 200-day SMA reached $2.5778. Nevertheless, trading volume fell to 3.52 million shares from 3.79 million shares the previous day.
Support And Resistance Levels for Bluebird bio Inc (BLUE)
According to the 24-hour chart, there is a support level at 1.1233, which, if violated, would cause prices to drop to 1.0867. In the upper region, resistance lies at 1.2133. The next price resistance is at 1.2667. RSI (Relative Strength Index) is 42.74 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0420, which suggests the price will decrease in the coming days. Percent R is at 76.32%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Bluebird bio Inc subject to short interest?
Stocks of Bluebird bio Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 5.45 million shares to 34.04 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 28.59 million shares. A jump of 16.01% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.91 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.91.
